Stem Cell Line Offerings, BioTime (AMEX:BTIM)
BTIM will be offering (8/1/10) for sale; 21 new stem cell products for research use only. These products will include the novel stem cell lines: E120 expressing the gene LGR5 useful in colon cancer drug discovery, EN16, T43, RAD20.5, RA-SKEL8, SM22, and Z1, full properties of which will be disclosed on product launch, along with differentiation kits and media for the culture of each line.
Categories: Stem Cell Technology
